Short description:
Genome Editing Technologies
Drug notes:
P-MUC1C-ALL01 Clin1 solid tumors; P-CD19CD20-ALLO1 Clin1 B-cell malignancies (partner: Roche); 4 programs Clin0 multiple cancers; P-OTC-101 Clin0 OTC deficiency; P-FVIII-101 Clin0 hemophilia A; P-PAH-101 Clin0 phenylketonuria
Long description:
Poseida Therapeutics is developing next-generation gene engineering technologies. Using their proprietary genetic engineering platform combining the piggyBac DNA Modification System, Cas-CLOVER Gene Editing System and Nanparticle/AAV Delivery Technology, Poseida is developing single treatment cures that efficiently deliver genetic cargo into cells. Poseida’s gene engineering technologies represent the next wave of innovation and brings hope to patients with cancer and genetic disease. Poseida is advancing product candidates including CAR-T therapies to harness the power of a patient’s own immune system.
Jobs:
Scientist II, Analytical Development San Diego, CA|Not provided
Director, Financial Reporting San Diego, CA|Not provided
Senior Process Engineer - MSAT San Diego, CA|Not provided
Senior Scientist, Clinical Biomarkers San Diego, CA|Not provided
Principal Scientist, Analytical Development San Diego, CA|Not provided
Senior Director, Partnership Finance San Diego, CA|Not provided
Associate Director, Translational Science - Gene T... San Diego, CA|Not provided
Research Scientist, Synthetic Chemistry San Diego, CA|Not provided
Research Scientist/Research Scientist II/Senior Re... San Diego, CA|Not provided
Research Associate I/II, Healthy Donor Core San Diego, CA|Not provided
Medical Science Liaison - WEST Remote|Not provided
Process Engineer San Diego, CA|Not provided
Director, Strategic Analytics San Diego, CA|Not provided